Phytoestrogens after breast cancer

Endocrine-Related Cancer

Volumn 8, Issue 2, 2001, Pages 129-134

  This, P ^a   De la Rochefordiere A ^a   Clough, K ^a   Fourquet, A ^a   Magdelenat, H ^a  

^a INSTITUT CURIE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIESTROGEN; PHYTOESTROGEN; TAMOXIFEN;

ADJUVANT CHEMOTHERAPY; BREAST CANCER; CANCER GROWTH; CARCINOGENESIS; CONFERENCE PAPER; ESTROGEN DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; MENOPAUSAL SYNDROME; PHYSICIAN ATTITUDE; RISK BENEFIT ANALYSIS; TREATMENT INDICATION;

ANIMALS; BREAST; BREAST NEOPLASMS; CLINICAL TRIALS; DIETARY SUPPLEMENTS; ESTROGEN ANTAGONISTS; ESTROGENS, NON-STEROIDAL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; ISOFLAVONES; PHYTOESTROGENS; PLANT PREPARATIONS; SOYBEANS; TAMOXIFEN;

EID: 0034952563     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.0.0080129     Document Type: Conference Paper

References (30)

1. The effects of dietary soy supplementation on hot flushes
2. Meta-analysis of the effects of soy protein intake on serum lipids
3. Dietary soy bean protein prevents bone loss in an ovariectomized rat model of osteoporosis
4. The chemopreventive properties of soy isoflavonoids in animal models of breast cancer
5. Intratumoral levels of estrogens in breast cancer
6. Comparison of estrogen concentration, estrone sulfatase and aromatase activities in normal, and in cancerous human breast tissues
7. Tamoxifen for early breast cancer: An overview of the randomized trials
8. Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin-releasing hormone agonists
9. Lack of significant hormonal effects and controlled trials of phytoestrogens
10. Two-week dietary supplementation has an estrogenic effect on normal premenopausal breast
11. Estrogenic effects on the growth of estrogen receptor-positive human breast cancer (MCF 7) cells in vitro and in vivo
12. Case-control study of phytoestrogen and breast cancer
13. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptor a and b
14. Neonatal genistein chemoprevents mammary cancer
15. Effects of soy-protein supplementation on epithelial proliferation in the histologically normal human breast
16. In vitro bioassays of non-steroidal phytoestrogens
17. Phytoestrogens interactions with estrogen receptors in human breast cancer cells
18. Phytoestrogens
19. Soy protein and isoflavones: Their effects on blood lipids and bone density in postmenopausal women
20. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial
21. Differential effects of dietary phytoestrogens daidzeine and equol on human breast cancer MCF7 cells
22. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk
23. Exposure of infants to phytoestrogens from soy-based infant formula
24. Phytoestrogens: The biochemistry, physiology, and implications for human health of soy isoflavones
25. Tamoxifen and genistein synergistically down-regulate signal transduction and proliferation in estrogen receptor negative human breast carcinoma MDA-MB-435 cells
26. Potential health benefits of dietary phytoestrogens: A review of the clinical epidemiological and mechanistic evidence
27. Estrogen replacement therapy after localized breast cancer. Clinical outcome of 319 women followed prospectively
28. Phytoestrogen concentrations determine effects on DNA synthesis in human breast cancer cells
29. Soy intake and risk of breast cancer in Asians and Americans
30. Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro